Progyny, Inc. (PGNY)
NASDAQ: PGNY · IEX Real-Time Price · USD
27.79
-0.23 (-0.82%)
At close: Jul 19, 2024, 4:00 PM
28.78
+0.99 (3.56%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
Progyny Market Cap
Progyny has a market cap or net worth of $2.65 billion as of July 22, 2024. Its market cap has decreased by -24.26% in one year.
Market Cap
2.65B
Enterprise Value
2.29B
1-Year Change
-24.26%
Ranking
Category
Stock Price
$27.79
Market Cap Chart
Since October 25, 2019, Progyny's market cap has increased from $1.31B to $2.65B, an increase of 102.01%. That is a compound annual growth rate of 16.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 2.65B | -25.74% |
| Dec 29, 2023 | 3.56B | 23.15% |
| Dec 30, 2022 | 2.89B | -36.46% |
| Dec 31, 2021 | 4.55B | 23.98% |
| Dec 31, 2020 | 3.67B | 59.18% |
| Dec 31, 2019 | 2.31B | 76.13% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SpringWorks Therapeutics | 2.79B |
| Bausch Health Companies | 2.79B |
| Apogee Therapeutics | 2.78B |
| Geron | 2.73B |
| Agios Pharmaceuticals | 2.65B |
| Kymera Therapeutics | 2.64B |
| Certara | 2.59B |
| Astrana Health | 2.52B |